Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Ulz Initiated (SNTI) at Hold and Held Target at $75 on, Oct 7th, 2022
Michael Ulz of Morgan Stanley, Initiated "Senti Biosciences, Inc." (SNTI) at Hold and Held Target at $75 on, Oct 7th, 2022.
Michael has made no other calls on SNTI in the last 4 months.
There are 2 other peers that have a rating on SNTI. Out of the 2 peers that are also analyzing SNTI, 0 agree with Michael's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michael
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $70 on, Thursday, September 29th, 2022
- Geulah Livshits of "Chardan Capital" Initiated at Strong Buy and Held Target at $120 on, Friday, September 23rd, 2022
